ZP3 and cancer: The publicly available RNAseq data of CCLs and tumor tissues, and our independent computational and qPCR analysis, provide a clear explanation for the cytoplasmic localization of ZP3 observed in cancer, as these data show that ZP3-Cancer is the dominant transcript in tumor cells.